USP25 and cardiac hypertrophy: DUBs are closely involved in the pathophysiological regulations of cardiac hypertrophy 8, and our research group also found that two DUBs (USP25 and JOSD2) can inhibit cardiac hypertrophy and dysfunction by stabilizing SERCA2a and thereby maintaining calcium handling in cardiomyocytes 21, 24.